[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Animal Therapeutics and Diagnostics Market Size study, by Product Type (Animal Diagnostics Products, Animal Therapeutics Products), by Animal Type (Companion Animals, Cattle, Pigs, Poultry, Sheep) and Country Forecasts 2022-2032

July 2024 | 200 pages | ID: E8C4BC6D6309EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Europe Animal Therapeutics and Diagnostics Market is valued at approximately USD 10.45 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.62 % over the forecast period 2024-2032. Animal Therapeutics and Diagnostics (ATD) is vital in veterinary medicine, focusing on treating and diagnosing animal health issues. This field encompasses drugs, vaccines, supplements, biological products, and surgical methods to improve animal well-being and prevent diseases. Diagnostic techniques include lab tests, imaging, molecular diagnostics, point-of-care testing, and biosensors to accurately detect and monitor health issues. ATD is crucial for protecting pets, farm animals, and wildlife, preventing zoonotic disease transmission, ensuring food safety, and supporting the agricultural and pet care markets. The Europe Animal Therapeutics and Diagnostics (ATD) Market is growing due to trends such as increased preventive healthcare for pets and livestock, driving demand for vaccines and supplements. The rising adoption of companion animals in urban areas boosts the need for advanced diagnostics and treatments. Personalized medicine in veterinary care is becoming prominent, with tailored treatments for individual animals. Digital health technologies, such as telemedicine and wearable devices, are also being adopted, enhancing veterinary care efficiency and accessibility.

The Europe Animal Therapeutics and Diagnostic market is propelled by increasing pet ownership and growing awareness of animal health, driving demand for quality veterinary care, including therapeutics and diagnostics. Technological advancements in veterinary medicine, such as new drugs and diagnostic tools, enhance treatment efficacy, fostering market growth. There's a shift towards preventive healthcare, with routine vaccinations and check-ups boosting demand. Rising companion animal adoption in urban areas fuels veterinary service needs. Personalized medicine trends tailor treatments to individual animal traits, driving innovation. However, challenges include high costs hindering accessibility, especially in developing markets. Regulatory hurdles and rigorous product approval processes delay market entry. The market's fragmentation, with many small to medium-sized firms, intensifies competition and pricing pressures.

The key countries considered for the Europe Animal Therapeutics and Diagnostics market study includes UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominates the Europe Animal Therapeutics and Diagnostic Market in terms of revenue, driven by its robust veterinary infrastructure and high concentration of clinics, hospitals, and research facilities. This foundation supports the development and adoption of advanced veterinary therapeutics and diagnostics. The country boasts a diverse and sizable pet population, including dogs, cats, and horses, fostering significant demand for veterinary services. German pet owners often view their animals as family members, promoting substantial investments in pet health and well-being. Moreover, Germany's advanced pharmaceutical and biotechnology sectors contribute to pioneering veterinary drugs and diagnostic technologies. A stringent regulatory framework ensures high standards for animal health products, further bolstering Germany's dominance in the market. The market in UK, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:
Bayer Animal Health GmbH
Boehringer Ingelheim Animal Health GmbH
Virbac GmbH
Vetoquinol SA
Laboratorios Ovejero S.A.
Esteve Veterinaria S.A
Fatro S.p.A.
Zoetis UK Limited
Dechra Veterinary Products Ltd
MSD Animal Health BV

The detailed segments and sub-segments of the market are explained below:

By Product Type
Animal Diagnostics Products
Animal Therapeutics Products

By Animal Type
Companion Animals
Cattle
Pigs
Poultry
Sheep
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
CHAPTER 1. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS

1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
  1.3.1. Inclusion & Exclusion
  1.3.2. Limitations
  1.3.3. Supply Side Analysis
    1.3.3.1. Availability
    1.3.3.2. Infrastructure
    1.3.3.3. Regulatory Environment
    1.3.3.4. Market Competition
    1.3.3.5. Economic Viability (Consumer’s Perspective)
  1.3.4. Demand Side Analysis
    1.3.4.1. Regulatory frameworks
    1.3.4.2. Technological Advancements
    1.3.4.3. Environmental Considerations
    1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Europe Animal Therapeutics and Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
  2.3.1. By Product Type
  2.3.2. By Animal Type
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion

CHAPTER 3. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET DYNAMICS

3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

CHAPTER 4. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model
  4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

CHAPTER 5. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY PRODUCT TYPE 2022-2032

5.1. Animal Diagnostics Products
5.2. Animal Therapeutics Products

CHAPTER 6. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY ANIMAL TYPE 2022-2032

6.1. Companion Animals
6.2. Cattle
6.3. Pigs
6.4. Poultry
6.5. Sheep

CHAPTER 7. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE & FORECASTS BY COUNTRY 2022-2032

7.1. U.K. Animal Therapeutics and Diagnostics Market
  7.1.1. Product Type breakdown size & forecasts, 2022-2032
  7.1.2. Animal Type breakdown size & forecasts, 2022-2032
7.2. Germany Animal Therapeutics and Diagnostics Market
7.3. France Animal Therapeutics and Diagnostics Market
7.4. Spain Animal Therapeutics and Diagnostics Market
7.5. Italy Animal Therapeutics and Diagnostics Market
7.6. Rest of Europe Animal Therapeutics and Diagnostics Market

CHAPTER 8. COMPETITIVE INTELLIGENCE

8.1. Key Company SWOT Analysis
  8.1.1. Company
  8.1.2. Company
  8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
  8.3.1. Bayer Animal Health GmbH
    8.3.1.1. Key Information
    8.3.1.2. Overview
    8.3.1.3. Financial (Subject to Data Availability)
    8.3.1.4. Product Summary
    8.3.1.5. Market Strategies
  8.3.2. Boehringer Ingelheim Animal Health GmbH
  8.3.3. Virbac GmbH
  8.3.4. Vetoquinol SA
  8.3.5. Laboratorios Ovejero S.A.
  8.3.6. Esteve Veterinaria S.A
  8.3.7. Fatro S.p.A.
  8.3.8. Zoetis UK Limited
  8.3.9. Dechra Veterinary Products Ltd
  8.3.10. MSD Animal Health BV

CHAPTER 9. RESEARCH PROCESS

9.1. Research Process
  9.1.1. Data Mining
  9.1.2. Analysis
  9.1.3. Market Estimation
  9.1.4. Validation
  9.1.5. Publishing
9.2. Research Attributes

LIST OF TABLES

TABLE 1. Europe Animal Therapeutics and Diagnostics market, report scope
TABLE 2. Europe Animal Therapeutics and Diagnostics market estimates & forecasts by Country 2022-2032 (USD Billion)
TABLE 3. Europe Animal Therapeutics and Diagnostics market estimates & forecasts by Product Type 2022-2032 (USD Billion)
TABLE 4. Europe Animal Therapeutics and Diagnostics market estimates & forecasts by Animal Type 2022-2032 (USD Billion)
TABLE 5. Europe Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Europe Animal Therapeutics and Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Europe Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe Animal Therapeutics and Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Europe Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Europe Animal Therapeutics and Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Europe Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Europe Animal Therapeutics and Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Europe Animal Therapeutics and Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Billion) Europe Animal Therapeutics and Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. UK Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. UK Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 16. UK Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. Germany Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 18. Germany Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 19. Germany Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. France Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 21. France Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 22. France Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. Italy Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 24. Italy Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 25. Italy Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Spain Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 27. Spain Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 28. Spain Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. RoE Animal Therapeutics and Diagnostics market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 30. RoE Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 31. RoE Animal Therapeutics and Diagnostics market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. List of secondary sources, used in the study of Europe Animal Therapeutics and Diagnostics Market.
TABLE 33. List of primary sources, used in the study of Europe Animal Therapeutics and Diagnostics Market.
TABLE 34. Years considered for the study.
TABLE 35. Exchange rates considered.

LIST OF FIGURES

FIG 1. Europe Animal Therapeutics and Diagnostics market, research methodology
FIG 2. Europe Animal Therapeutics and Diagnostics market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Animal Therapeutics and Diagnostics market, key trends 2023
FIG 5. Europe Animal Therapeutics and Diagnostics market, growth prospects 2022-2032
FIG 6. Europe Animal Therapeutics and Diagnostics market, porters 5 force model
FIG 7. Europe Animal Therapeutics and Diagnostics market, pestel analysis
FIG 8. Europe Animal Therapeutics and Diagnostics market, value chain analysis
FIG 9. Europe Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 10. Europe Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 11. Europe Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 12. Europe Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 13. Europe Animal Therapeutics and Diagnostics market by segment, 2022 & 2032 (USD Billion)
FIG 14. Europe Animal Therapeutics and Diagnostics market, Country snapshot 2022 & 2032
FIG 15. Europe Animal Therapeutics and Diagnostics market 2022 & 2032 (USD Billion)
FIG 16. Europe Animal Therapeutics and Diagnostics market, company market share analysis (2023)


More Publications